Literature DB >> 25323660

Persistent centripetal fat distribution and metabolic abnormalities in patients in long-term remission of Cushing's syndrome.

Margreet Wagenmakers1, Sean Roerink, Linda Gil, Theo Plantinga, Jan Smit, Romana Netea-Maier, Ad Hermus.   

Abstract

OBJECTIVE: Centripetal obesity is associated with systemic low-grade inflammation and an increased cardiovascular risk. Patients in long-term remission of Cushing's syndrome (CS) report persisting abdominal fat accumulation. However, this has previously not been adequately objectified. Therefore, we investigated the adipose tissue distribution and adipocytokine profiles of patients in long-term remission of CS.
DESIGN: Cross-sectional case-control study in a tertiary referral centre. PATIENTS: Fifty-eight patients, in remission of CS for at least 5 years, were compared to 58 age-, gender- and BMI-matched healthy control subjects. MEASUREMENTS: Measures of body composition (assessed with clinical evaluation and dual-energy X-ray absorptiometry (DEXA) scanning) and serum adipocytokine profiles.
RESULTS: Compared to the matched control subjects, patients in long-term remission of CS had a greater waist circumference (P < 0·01), a smaller thigh circumference (P < 0·01), a higher waist-to-hip ratio (P < 0·01) and a higher hip-to-thigh ratio (P < 0·01). As measured with DEXA scanning, patients had a higher percentage of truncal fat mass (P = 0·01), and the truncal fat mass to leg fat mass ratio was greater (P < 0·01). Patients had lower adiponectin levels (P < 0·01), higher leptin levels (P < 0·01) and higher resistin levels (P = 0·04) than control subjects.
CONCLUSION: Even after long-term remission, patients who suffered from CS in the past continue to have a centripetal adipose tissue distribution and an adverse adipokine profile. This is independent of aetiology of the CS, treatment strategies, hormonal deficiencies and comorbidity, and probably contributes to the persistent increased cardiovascular risk.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25323660     DOI: 10.1111/cen.12639

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  Left ventricular geometry and 24-h blood pressure profile in Cushing's syndrome.

Authors:  Eleonora Avenatti; Andrea Rebellato; Andrea Iannaccone; Marialberta Battocchio; Francesca Dassie; Franco Veglio; Alberto Milan; Francesco Fallo
Journal:  Endocrine       Date:  2016-05-14       Impact factor: 3.633

2.  Insulin sensitivity and secretion and adipokine profile in patients with Cushing's disease treated with pasireotide.

Authors:  V Guarnotta; G Pizzolanti; A Ciresi; C Giordano
Journal:  J Endocrinol Invest       Date:  2018-02-02       Impact factor: 4.256

3.  A prospective study of appetite and food craving in 30 patients with Cushing's disease.

Authors:  Eliza B Geer; Yelena Lalazar; Lizette M Couto; Vanessa Cohen; Lianna R Lipton; Wei Shi; Emilia Bagiella; Irene Conwell; Joshua Bederson; Jane Kostadinov; Kalmon D Post; Pamela U Freda
Journal:  Pituitary       Date:  2016-04       Impact factor: 4.107

4.  Glucocorticoid receptor polymorphisms modulate cardiometabolic risk factors in patients in long-term remission of Cushing's syndrome.

Authors:  Sean H P P Roerink; M A E M Wagenmakers; J W A Smit; E F C van Rossum; R T Netea-Maier; T S Plantinga; A R M M Hermus
Journal:  Endocrine       Date:  2016-02-13       Impact factor: 3.633

Review 5.  Stress and Obesity: Are There More Susceptible Individuals?

Authors:  Eline S van der Valk; Mesut Savas; Elisabeth F C van Rossum
Journal:  Curr Obes Rep       Date:  2018-06

6.  Decreased Aerobic Exercise Capacity After Long-Term Remission From Cushing Syndrome: Exploration of Mechanisms.

Authors:  Sean H P P Roerink; Matthew S Cocks; Margreet A E M Wagenmakers; Raffaella P Rodighiero; Juliette A Strauss; Sam O Shepherd; Theo S Plantinga; Dick H J Thijssen; Maria T E Hopman; Alberto M Pereira; Jan W Smit; Anton J M Wagenmakers; Romana T Netea-Maier; Ad R M M Hermus
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

Review 7.  Cardiovascular complications of Cushings syndrome: Impact on morbidity and mortality.

Authors:  Richard N Clayton
Journal:  J Neuroendocrinol       Date:  2022-06-28       Impact factor: 3.870

8.  Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas.

Authors:  Matthias K Auer; Günter K Stalla; Mareike R Stieg
Journal:  Pituitary       Date:  2016-10       Impact factor: 4.107

9.  Increased oxidative stress, inflammation and fibrosis in perirenal adipose tissue of patients with cortisol-producing adenoma.

Authors:  Chunyan Wu; Huijian Zhang; Jiajun Zhang; Hongbin Zhang; Yanmei Zeng; Shu Fang; Ping Li; Yudan Zhang; Xiaochun Lin; Ling Wang; Yaoming Xue; Meiping Guan
Journal:  Adipocyte       Date:  2019-12       Impact factor: 4.534

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.